News & Articles
Rappta Therapeutics Appoints Sunjeet Sawhney as Chief Executive Officer
Rappta Therapeutics announces today the appointment of Sunjeet Sawhney as Chief Executive Officer (CEO) with immediate effect. Rappta’s Co-founder and Founding CEO Mikko Mannerkoski will move to be Chief Financial Officer (CFO) as planned.
Read more
Rappta Therapeutics Raises Series A Financing for the Development of Phosphatase 2A drugs
Unique phosphatase technology platform offers a new paradigm in oncology. EUR 9M financing, co-led by NVF and Novo Seeds with participation from Advent Life Sciences and a family office, to advance lead compounds to clinical candidate stage.
Read more